281 related articles for article (PubMed ID: 35873373)
1. Applications and perspectives of polyphenol-loaded solid lipid nanoparticles and nanostructured lipid carriers for foods.
Kim E; Ban C; Kim SO; Lim S; Choi YJ
Food Sci Biotechnol; 2022 Jul; 31(8):1009-1026. PubMed ID: 35873373
[TBL] [Abstract][Full Text] [Related]
2. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.
Naseri N; Valizadeh H; Zakeri-Milani P
Adv Pharm Bull; 2015 Sep; 5(3):305-13. PubMed ID: 26504751
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
4. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
5. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages.
Ghasemiyeh P; Mohammadi-Samani S
Res Pharm Sci; 2018 Aug; 13(4):288-303. PubMed ID: 30065762
[TBL] [Abstract][Full Text] [Related]
7. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
8. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
Neves AR; Lúcio M; Martins S; Lima JL; Reis S
Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
[TBL] [Abstract][Full Text] [Related]
9. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
[TBL] [Abstract][Full Text] [Related]
11. Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects.
Shi F; Wei Z; Zhao Y; Xu X
Pharmacogn Mag; 2016; 12(47):198-202. PubMed ID: 27601850
[TBL] [Abstract][Full Text] [Related]
12. Methods for preparation of nanostructured lipid carriers.
Gomaa E; Fathi HA; Eissa NG; Elsabahy M
Methods; 2022 Mar; 199():3-8. PubMed ID: 33992771
[TBL] [Abstract][Full Text] [Related]
13. In vitro digestion of edible nanostructured lipid carriers: Impact of a Candelilla wax gelator on performance.
Sislioglu K; Gumus CE; Koo CKW; Karabulut I; McClements DJ
Food Res Int; 2021 Feb; 140():110060. PubMed ID: 33648283
[TBL] [Abstract][Full Text] [Related]
14. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
15. Optimized Nanoparticles for Enhanced Oral Bioavailability of a Poorly Soluble Drug: Solid Lipid Nanoparticles Versus Nanostructured Lipid Carriers.
Darwish MKM; El-Enin ASMA; Mohammed KHA
Pharm Nanotechnol; 2022; 10(1):69-87. PubMed ID: 35142275
[TBL] [Abstract][Full Text] [Related]
16. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
17. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
18. Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors.
Mehrdadi S
Adv Pharm Bull; 2023 Jul; 13(3):512-520. PubMed ID: 37646057
[TBL] [Abstract][Full Text] [Related]
19. Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers.
Zhou J; Zhou D
Drug Des Devel Ther; 2015; 9():5269-75. PubMed ID: 26425076
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
Das S; Chaudhury A
AAPS PharmSciTech; 2011 Mar; 12(1):62-76. PubMed ID: 21174180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
